Antonio Martínez-Lara

Antonio Martínez-Lara

Auto-generated profile, based on publicly available information

Antonio Martínez-Lara

Pronacera, Avenida de la Ingeniería 9, Local 34, Parque Empresarial Arte Sacro (PEASS), 41015 Seville, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Open access
JPJuan Francisco Palma‐Ordóñez
Juan Francisco Palma‐Ordóñez
AMAna María Moreno‐Fernández
Ana María Moreno‐Fernández
Jorge Antolín Ramírez TejeroJorge Antolín Ramírez Tejero
Jorge Antolín Ramírez Tejero
EGElena Durán González
Elena Durán González
AMAntonio Martínez‐Lara
Antonio Martínez‐Lara
DCDavid Cotán
David Cotán
Fibromyalgia (FM) is a highly prevalent chronic disease. About 4.7% of the world's population suffers from generalized pain and hypersensitivity, in addition to a wide range of physical and psychological symptoms. The etiopathogenesis of this disease is multifactorial, which makes its diagnosis and treatment challenging. Recently, the increase in the number of studies on microbiota has provided new data that can help to understand the onset and development of FM. An updated systematic review of the causes of FM has been carried out in this work. Particularly in the last decade, research has focused on the gut–brain axis, which has emerged as a crucial mechanism for microbiota‐host crosstalk. In FM patients, quantitative imbalances of the intestinal microbiota (dysbiosis) and bacterial metabolites with differential relative abundance have been found, especially short‐chain fatty acids and lipopolysaccharides. Furthermore, the microbiota has been found to indirectly influence host neurotransmitter mechanisms, mainly through the serotonin precursor, glutamate, and gamma‐aminobutyric acid. Thus, all these mechanisms and their influence on the etiopathogenesis of FM are discussed in this review.

1 August 2020 in Open Access Rheumatology: Research and Reviews
Verified
Journal Article
Open access
PDF file
AMAntonio Martínez-Lara
Antonio Martínez-Lara
AMAna María Moreno-Fernández
Ana María Moreno-Fernández
MJMaripaz Jiménez-Guerrero
Maripaz Jiménez-Guerrero
CDClaudia Díaz-López
Claudia Díaz-López
MDManuel De-Miguel
Manuel De-Miguel
JSJosé Antonio Sánchez-Alcázar
José Antonio Sánchez-Alcázar
Background: Fibromyalgia (FM) is a common chronic pain disease, whose pathogenic mechanism still remains elusive. Oxidative stress markers and impaired bioenergetics homeostasis have been proposed as relevant events in the pathogenesis of the disease. Hence, the aim of the study is to analyse the potential biomarkers of mitochondrial imbalance in FM patients along with coenzyme Q10 (CoQ10) as a possible treatment. Methods: The symptomatology of patients was recorded with an adaption of the Fibromyalgia Impact Questionnaire (FIQ). Mitochondrial imbalance was tested from blood extraction and serum isolation in 33 patients diagnosed with FM and 30 healthy controls. Western blot and HPLC techniques were performed to study the different parameters. Finally, bioinformatic analysis of machine learning was performed to predict possible associations of results. Results: CoQ10 parameter did not show evidence to be a good marker of the disease, as the values are not significantly different between control and patient groups (Student’s t-test, CI 95%). For this reason, the focus of the study changed into the ratio between mitochondrial mass and autophagy levels. The bioinformatics analysis showed a possible association between this ratio and patients’ symptomatology. Finally, the effects of coenzyme Q10 as a potential treatment for the disease were different within patients, and its efficacy may be related to the initial mitochondrial status. However, there is no statistical significance due to limitations within the sample size. Conclusion: Our study supports the hypothesis that an imbalance in mitochondrial homeostasis is involved in the FM pathogenesis. However, whether the increase in oxidative stress is the result of mitochondrial imbalance or the cause of this disease remains an open question. The measurement of this imbalance might be used as a preliminary biomarker for the diagnosis and follow-up of patients with FM, and even for the evaluation of the effects of the different antioxidants therapies.

12 July 2023 in Neurology International
Verified
Journal Article
Open access
PDF file
Jorge Antolín Ramírez TejeroJorge Antolín Ramírez Tejero
Jorge Antolín Ramírez Tejero
EGElena Durán González
Elena Durán González
AMAntonio Martínez-Lara
Antonio Martínez-Lara
LALaura Lucena del Amo
Laura Lucena del Amo
ISIsabel Sepúlveda
Isabel Sepúlveda
DCDavid Cotán
David Cotán
Fibromyalgia is a widespread chronic condition characterized by pain and fatigue. Among the long list of physiological disturbances linked to this syndrome, mitochondrial imbalance and oxidative stress stand out. Recently, the crosstalk between mitochondria and intestinal microbiota has caught the attention of biomedical researchers, who have found connections between this axis and several inflammatory and pain-related conditions. Hence, this pilot descriptive study focused on characterizing the mitochondrial mass/mitophagy ratio and total antioxidant capacity in PBMCs, as well as some microbiota components in feces, from a Peruvian cohort of 19 females and 7 males with FM. Through Western blotting, electrochemical oxidation, ELISA, and real-time qPCR, we determined VDAC1 and MAP1LC3B protein levels; total antioxidant capacity; secretory immunoglobulin A (sIgA) levels; and Firmicutes/Bacteroidetes, Bacteroides/Prevotella, and Roseburia/Eubacterium ratios; as well as Ruminococcus spp., Pseudomonas spp., and Akkermansia muciniphila levels, respectively. We found statistically significant differences in Ruminococcus spp. and Pseudomonas spp. levels between females and males, as well as a marked polarization in mitochondrial mass in both groups. Taken together, our results point to a mitochondrial imbalance in FM patients, as well as a sex-dependent difference in intestinal microbiota composition.

26 May 2026 in Life
Verified
Journal Article
Open access
PDF file
EGElena Durán González
Elena Durán González
Jorge Antolín Ramírez TejeroJorge Antolín Ramírez Tejero
Jorge Antolín Ramírez Tejero
IMIsmael San Mauro Martin
Ismael San Mauro Martin
ALAna Terrén Lora
Ana Terrén Lora
MSMarta Pérez Sánchez
Marta Pérez Sánchez
DCDavid Cotán
David Cotán
Fibromyalgia is a chronic syndrome associated with pain, fatigue, and cognitive symptoms, often linked to gut microbiota alterations. The Mediterranean Diet (MD), particularly extra-virgin olive oil (EVOO), has antioxidant and anti-inflammatory properties that may beneficially modulate the microbiota. We conducted a prospective, randomized, double-blind, placebo-controlled clinical trial that included 250 women (206 with fibromyalgia, 44 controls). Participants followed a MD supplemented with EVOO or refined olive oil (placebo) for six months. Microbiota composition was analyzed at four time points (T0–T3) by 16S rRNA sequencing (V3–V4). At baseline, fibromyalgia patients exhibited reduced microbial diversity compared to controls. While global diversity did not change after intervention, specific taxa increased significantly with EVOO, including Bacteroides fragilis, Anaerotruncus colihominis, Adlercreutzia equolifaciens, and butyrate producers such as Faecalibacterium prausnitzii, Roseburia intestinalis, and Agathobacter. These shifts suggest EVOO supplementation might promote anti-inflammatory and metabolic bacteria, suggesting diet as a complementary strategy to modulate gut microbiota in fibromyalgia.